kca 098 has been researched along with Osteoporosis in 2 studies
*Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, N; Endo, H; Itoh, F; Kawashima, K; Kojima, M; Nagata, H; Tsutsumi, N; Tsuyuki, J; Ujiie, A | 1 |
Anraku, M; Imai, T; Otagiri, M; Saito, N; Yamada, T | 1 |
2 other study(ies) available for kca 098 and Osteoporosis
Article | Year |
---|---|
Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Bone and Bones; Bone Density; Bone Resorption; Calcification, Physiologic; Calcium; Calcium, Dietary; Chick Embryo; Coumestrol; Dinoprostone; Female; Femur; Interleukin-1; Isoflavones; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Wistar | 1994 |
Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion
Topics: Absorption; Animals; Cellulose; Coumestrol; Crystallization; Dogs; Male; Osteoporosis; Powders; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2000 |